Zurich Cantonal Bank’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,284
Closed -$6.83K 2795
2023
Q2
$6.83K Hold
2,284
﹤0.01% 2755
2023
Q1
$7.9K Hold
2,284
﹤0.01% 2806
2022
Q4
$9.55K Hold
2,284
﹤0.01% 2808
2022
Q3
$9K Hold
2,284
﹤0.01% 2865
2022
Q2
$26K Sell
2,284
-6,887
-75% -$82.6K ﹤0.01% 2753
2022
Q1
$149K Sell
9,171
-1,432
-14% -$36.7K ﹤0.01% 2079
2021
Q4
$502K Sell
10,603
-7,849
-43% -$471K ﹤0.01% 1438
2021
Q3
$1.34M Buy
18,452
+4,914
+36% +$355K 0.01% 846
2021
Q2
$1.14M Buy
13,538
+12,389
+1,078% +$817K 0.01% 859
2021
Q1
$56K Buy
+1,149
New +$62.3K ﹤0.01% 2361

Other funds holding NBP

Zurich Cantonal Bank's NBP Position: Q3 2023 in Review

Zurich Cantonal Bank sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 2,284 shares — an estimated $6.83K sold.

Zurich Cantonal Bank first reported a position in NBP in Q1 2021 and held it in 10 quarters. The position peaked at $1.34M in Q3 2021. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • Zurich Cantonal Bank reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,284 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $6.83K.
  • Zurich Cantonal Bank first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 10 quarters.
  • Zurich Cantonal Bank's NovaBridge Biosciences American Depositary Shares position peaked at $1.34M in Q3 2021.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Zurich Cantonal Bank's 13F filing for Q3 2023, filed 25 Oct 2023.